Dr. Edgardo Santos' Interview with Hope Rugo, MD
Update: 2025-08-25
Description
Interviews with Summit Director Edgardo S. Santos Castillero, MD, FACP, FASCO
NOSCM 2024 | New Orleans Summer Cancer Meeting
Dr. Edgardo Santos' Interview with Hope Rugo, MD
Dr. Santos discussed the breast cancer session that Dr. Rugo curated addressing current controversies and innovations—highlighting how antibody–drug conjugates (ADCs) like those in the DESTINY Breast 06 trial are effective even at very low HER2 expression—and exploring the promise of combining ADCs with immunotherapy to broaden treatment options across HER2-positive, hormone-receptor-negative, and triple-negative subtypes.
Comments
In Channel